There are obviously plenty of headwinds facing both the domestic and global economies which in turn have some investors questioning whether the near term direction of the share market is down.

While further falls could quite possibly lie ahead, the long term outlook for high-quality growth companies remains positive.

Here are three stocks with positive long-term growth dynamics.

iSentia Group Ltd (ASX: ISD) is a leading domestic provider of media intelligence. iSentia’s offering involves the monitoring and analysis of a vast array of media channels via its software and systems. Importantly, iSentia has expanded its services into Asia, which offers the group a significant opportunity for regional growth.

iSentia’s share price has fallen around 20% in calendar year 2016 and is arguably more attractive today at just under $4.

According to the latest available monthly Listed Investment Company Report provided by the ASX, as at April 30, Flagship Investments Ltd (ASX: FSI) was trading at a near 20% discount to its pre-tax net tangible asset (NTA) backing. Flagship owns a portfolio of growth stocks including major holdings in REA Group Limited (ASX: REA), SEEK Limited (ASX: SEK) and Carsales.Com Ltd (ASX: CAR).

With the share price currently trading at $1.45, the large discount to NTA would appear to make this stock an appealing way for investors to gain exposure to a portfolio of growth stocks at an attractive price.

Integrated Research Limited (ASX: IRI) is engaged in the development and provision of monitoring and management software for business critical computing infrastructure. The company can boast of its software servicing clients across over 50 countries and including some of the largest banks and telecommunications companies in the world.

With the share price at $2.05 and consensus earnings for financial year 2017 of 11.4 cents per share, Integrated Research’s shares could be a good buy for long-term growth. (source: Reuters)

Could these just released franked dividend picks turn $15,000 into over $30,000?

Get your portfolio growing today! When renowned dividend investing pros like Andrew Page issue buy alerts, it pays to listen. Because investors who followed Andrew's recommendation of Australian Pharmaceuticals in early 2015 could've doubled their money in just over a year, turning $15,000 into over $30,000 by the time he recommended they sell and lock in their profits. Chances are you won't want to miss uncovering the names of Andrew's newest share recommendation and short list of 3 dividend Best Buys Now Shares.
So click here to learn more about these potentially life-changing shares.

HOT OFF THE PRESSES: Motley Fool’s #1 Dividend Pick for 2017!

With its shares up 155% in just the last five years, this ‘under the radar’ consumer favourite is both a hot growth stock AND our expert’s #1 dividend pick for 2017. Now we’re pulling back the curtain for you... And all you have to do to discover the name, code and a full analysis is enter your email below!

Simply enter your email now to receive your copy of our brand-new FREE report, “The Motley Fool’s Top Dividend Stock for 2017.”

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our https://www.fool.com.au/financial-services-guide">Financial Services Guide (FSG) for more information.

Motley Fool contributor Tim McArthur has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.